Contributor
Dr Helen Bright, By Drug Target Review2026-05-22T07:38:00
As antimicrobial resistance grows and patient populations become more complex, the limitations of antibiotics are becoming harder to ignore. Dr Helen Bright, CSO at Centauri Therapeutics, discusses a new approach that targets both the pathogen and the host.
Antibacterial drug discovery has traditionally focused on identifying compounds that inhibit or kill pathogens. However, clinical outcomes depend on more than bacterial susceptibility alone. The immune system plays a critical role in clearing infection and when that response is impaired, even effective antibiotics can fall short. In response, approaches that combine direct antibacterial activity with immune engagement are being developed to address both pathogen burden and host response. Dr Helen Bright, Chief Scientific Officer at Centauri Therapeutics, is working in this area, focusing on the Alphamer® platform, which recruits naturally occurring antibodies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2026-06-04T07:05:00
Author Graham Craig
2026-06-29T06:49:00
Contributor Laura Alvarez, By Drug Target Review
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
2026-07-10T06:15:00
Contributor Professor Donald E Ingber, By Drug Target Review
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
2026-07-08T07:58:00
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-11-18T07:00:00Z Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-11-16T07:00:00Z Author Dr Martin Baraibar
2026-11-13T07:00:00Z Contributor Dr Panos Roussos, By Drug Target Review
2026-11-11T07:35:00Z By Dr Harsh Shah
Site powered by Webvision Cloud